REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,043,261 | +16.8% | 365,029 | +3.9% | 0.16% | +20.6% |
| Q2 2023 | $49,708,337 | -18.1% | 351,395 | -2.6% | 0.13% | -12.7% |
| Q1 2023 | $60,724,084 | +100209.0% | 360,680 | +0.9% | 0.15% | -5.7% |
| Q4 2022 | $60,537 | -99.9% | 357,551 | -1.0% | 0.16% | -20.1% |
| Q3 2022 | $67,564,000 | +18.8% | 361,089 | +3.1% | 0.20% | +25.9% |
| Q2 2022 | $56,874,000 | -12.2% | 350,210 | +1.7% | 0.16% | -1.2% |
| Q1 2022 | $64,761,000 | -26.2% | 344,311 | +3.9% | 0.16% | -22.0% |
| Q4 2021 | $87,769,000 | -12.7% | 331,401 | -4.7% | 0.20% | -20.2% |
| Q3 2021 | $100,488,000 | +21.9% | 347,722 | -15.8% | 0.26% | +20.1% |
| Q2 2021 | $82,449,000 | +31.8% | 413,027 | +28.3% | 0.21% | +22.3% |
| Q1 2021 | $62,573,000 | -3.1% | 321,863 | -4.5% | 0.18% | -9.3% |
| Q4 2020 | $64,608,000 | +28.4% | 337,151 | -1.1% | 0.19% | +12.2% |
| Q3 2020 | $50,303,000 | +14.9% | 340,948 | -3.7% | 0.17% | +4.2% |
| Q2 2020 | $43,783,000 | – | 354,203 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |